Syensqo, Inc. (OTCMKTS: SHBBF), formerly known as Applied DNA Sciences, is a molecular sciences company specializing in the development and commercialization of DNA-based authentication, traceability, and molecular diagnostic solutions. Leveraging proprietary SigNature® molecular tags and VeriFied® DNA testing assays, the company offers a platform designed to secure supply chains, protect intellectual property, and deliver environmental and food-safety monitoring. Syensqo’s core technology applies synthetic DNA markers that can be integrated into raw materials, packaging, and products to enable end-to-end verification.
The company’s product portfolio includes SigNature® T molecular tracers for anti-counterfeiting applications, VeriFied® antimicrobial efficacy testing assays, and botanical identification kits that support the food, beverage, and dietary supplement industries. Syensqo also provides contract research and laboratory testing services, offering custom assay development for clients in pharmaceuticals and agriculture. Their molecular diagnostics expertise extends to pathogen detection and environmental monitoring through high-sensitivity PCR-based workflows.
Since its founding in 1995 and headquartered in Stony Brook, New York, Syensqo has pursued strategic collaborations with government agencies, academic institutions, and commercial partners. While its primary operations are based in the United States, the company has established distribution and service agreements across Europe and Asia to support global supply-chain integrity initiatives. Industries served include pharmaceuticals, consumer goods, cosmetics, agriculture, and government contracts focused on biosecurity.
Under the leadership of President and Chief Executive Officer James C. Hayward, Syensqo continues to expand its R&D capabilities and pursue commercial adoption of its molecular tagging and testing solutions. The company’s mission centers on advancing molecular intelligence to address challenges in product authentication, regulatory compliance, and public health.
AI Generated. May Contain Errors.